BASIS OF PRESENTATION AND SUMMARY OF ACCOUNTING POLICIES - Summary of revenues disaggregated by our business operations and timing of revenue recognition (Details) - USD ($)	12 Months Ended
	Sep. 30, 2021	Sep. 30, 2020
Disaggregation of Revenue
Total	$ 9,027,738	$ 1,931,497
Research and development services (over-time)
Disaggregation of Revenue
Total	799,718	1,128,511
Clinical laboratory testing services (point-in-time)
Disaggregation of Revenue
Total	4,794,154	77,550
Supply chain
Disaggregation of Revenue
Total	1,003,248	38,577
Asset marking
Disaggregation of Revenue
Total	458,409	404,888
Large scale DNA production
Disaggregation of Revenue
Total		$ 281,971
Diagnostic kits
Disaggregation of Revenue
Total	$ 1,972,209